Thursday 15 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
2
Average plausibility
80%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
01HealthAfrica

Kenya confirms second Ebola case

Two outlets report a second confirmed case, while separate coverage raises concerns about preparedness in remote communities.

BBC News and France 24 report that Kenya has confirmed a second Ebola case. The BBC identifies the patient as a relative of the first victim, a man who died last week after arriving from DR Congo. Al Jazeera reports gaps in outbreak readiness beyond Nairobi.

What holds up

  • ✓The second confirmed case is reported by both BBC News and France 24.
  • ✓The BBC provides a family link between the cases and a travel history for the first victim, although neither detail is independently corroborated in the supplied items.

What doesn't yet

  • ?The items provide no laboratory records, contact-tracing results or evidence establishing where transmission occurred.
  • ?Al Jazeera's assessment of preparedness gaps comes without specific facilities, measures or supporting figures in the extract.

Ask before you share

  • →What do testing and contact-tracing records establish about the link between the cases?
  • →Which communities lack outbreak-response capacity, and what support is being provided?

Sources & original reporting

  1. [1]BBC News · Published 14 Oct 2026 · bbc.co.uk
  2. [2]Al Jazeera · Published 15 Oct 2026 · aljazeera.com
  3. [3]France 24 · Published 14 Oct 2026 · france24.com
02HealthAfrica

Guinea-Bissau denies authorising newborn hepatitis B trial

The health minister says the government has not approved the proposed Danish-led study.

The Guardian reports that Guinea-Bissau's health minister denied government authorisation for a Danish-led hepatitis B trial in newborns. The item describes the study as backed by RFK Jr and says it would be funded by the US government and private partners. The supplied extract does not include approval documents or a response from the study organisers.

What holds up

  • ✓The Guardian attributes the denial directly to Guinea-Bissau's health minister.
  • ✓The proposed study is identified as a Danish-led hepatitis B trial involving newborns.

What doesn't yet

  • ?The minister's statement is not accompanied by regulatory or ethics records establishing the trial's formal status.
  • ?The extract supplies neither the study protocol nor the organisers' account; the prospective funding arrangements are not documented.

Ask before you share

  • →What do national regulatory and ethics committee records show about authorisation?
  • →What are the proposed protocol, safeguards and funding commitments?

Sources & original reporting

  1. [1]The Guardian · Published 14 Oct 2026 · theguardian.com